Twelfth Version of Living Guideline Issued for Drugs for COVID-19
Physician's Weekly,
FRIDAY, Sept. 16, 2022 (HealthDay News) — In the living guideline developed by the World Health Organization and published in…
FRIDAY, Sept. 16, 2022 (HealthDay News) — In the living guideline developed by the World Health Organization and published in…
The antibody drugs sotrovimab and casirivimab-imdevimab are not recommended for patients with covid-19, says a WHO Guideline…
Two COVID-19 antibody therapies are no longer recommended by the World Health Organization (WHO), on the basis that Omicron and…
FRIDAY, July 15, 2022 (HealthDay News) — Fluvoxamine and colchicine are not recommended for nonsevere COVID-19, according to…
Helen Macdonald, The BMJ's research integrity editor is back with another episode, and this week is joined by Joe Ross…
Management of Drug Interactions With Nirmatrelvir/Ritonavir (Paxlovid®): Resource for Clinicians – Infectious Diseases Society…
Covid-19: What is the evidence for the antiviral Paxlovid? – The…
MONDAY, April 25, 2022 (HealthDay News) — In the living guideline developed by the World Health Organization and published in…
If you come down with COVID-19, antiviral drugs can help control the infection. Here's who could benefit most from them -- and…
WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator …
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19…
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New…
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New…
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New…
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New…
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New…
FRIDAY, March 4, 2022 (HealthDay News) — Molnupiravir is recommended for patients with nonsevere COVID-19 who are at the…
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New…
BMJ News Release: WHO recommends antiviral drug for patients with non-severe covid-19 at highest risk of hospital admission …
Организация советует назначать его больным с легкой формой ковида, но высоким риском госпитализации
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New…
This is part of the ongoing series of articles updating the evidence on current COVID-19 therapies. The rest of the series can…
This is part of the ongoing series of articles updating the evidence on current COVID-19 therapies. The rest of the series can…
News release: WHO recommends two new drugs to treat COVID-19 – World Health…
FRIDAY, Jan. 14, 2022 (HealthDay News) — The Janus kinase (JAK) inhibitor baricitinib is strongly recommended for patients with…
Это препарат от ревматоидного артрита и моноклональные антитела
In COVID-19 clinical update #92, Dr. Griffin reviews emerging data on the Omicron variant, much information about monoclonal…
News Release: WHO recommends against the use of convalescent plasma to treat COVID-19 – World Health…
Advisory strongly recommended against its use in clinical…
Эксперты советуют использовать ее только в рамках клинических испытаний при тяжелых формах болезни
12 vs 6 mg/d dexa did not increase days alive without life support at 28…
In COVID-19 clinical update #85, Dr. Griffin reviews cases and deaths by vaccination status, mRNA vaccine effectiveness in 12-18…
FRIDAY, Sept. 24, 2021 (HealthDay News) — Use of two recombinant human monoclonal antibodies that bind to the severe acute…
WHO recommends antibody treatment for COVID patients at high risk of hospital admission – British Medical…
A panel of international experts representing the World Health Organization (WHO) has recommended that high-risk COVID-19…
Prevention Our most effective weapons are lockdowns, masks, distancing, ventilation and vaccination, but we can also protect…
MONDAY, Nov. 23, 2020 (HealthDay News) — The use of remdesivir currently is not recommended for hospitalized COVID-19 patients…
Uncertainty abounds - even as we get better data on treatments, with the big RCTs beginning to report, and new trials on masks…
Niedługo po tym, jak dyrektor Europejskiego Stowarzyszenia Medycyny Intensywnej przestrzegał przed działaniem remdesiviru, w…
#15,570While everyone is hoping for an effective therapeutic against COVID-19 - and we've seen many drugs touted as possibly…